Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2012

01.10.2012 | Gynecologic Oncology

Predictors of resectability in breast-conserving therapy

verfasst von: Michelle G. Rath, Joerg Heil, Christoph Domschke, Zdravka Topic, Sven Schneider, Hans-Peter Sinn, Frederik Marme, Alexander Scharf, Andreas Schneeweiss, Christof Sohn, Joachim Rom

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Our goal is to identify subgroups of women undergoing breast-conserving therapy (BCT) who are at increased risk for requiring a secondary surgical procedure, and to identify tumor and patient profiles that will allow surgeons to anticipate the need for taking larger margins when removing the tumor.

Methods

One hundred female patients who had palpable, invasive carcinomas of the breast, and had undergone a primary BCT, were included in the study. Of these, all women (n = 25) who had incomplete resections, or questionable margins of resection, had to undergo re-excisions.

Results

Patients who had multifocal disease, accompanying ductal carcinoma in situ, involvement of regional lymph nodes, high-grade breast cancer (Grade 3 vs. 1/2), lympho-vascular invasion or negative hormone-receptor-status, were significantly more likely to have undergone incomplete removal of tumor tissue—these patients thus required a secondary surgery.

Conclusion

The clinical and pathological predictors described above indicate that surgery in breast cancer patients meeting these criteria require larger safety margins to minimize the incidence rate of re-excision at a later date.
Literatur
1.
Zurück zum Zitat Robert-Koch-Institut., G.d.e.K.u.d. (2006) Krebs in Deutschland Robert-Koch-Institut., G.d.e.K.u.d. (2006) Krebs in Deutschland
2.
Zurück zum Zitat Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef
3.
Zurück zum Zitat Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F (2007) Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14:1458–1471PubMedCrossRef Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F (2007) Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14:1458–1471PubMedCrossRef
4.
Zurück zum Zitat Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed
5.
Zurück zum Zitat van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst 92:1143–1150PubMedCrossRef van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst 92:1143–1150PubMedCrossRef
6.
Zurück zum Zitat Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef
7.
Zurück zum Zitat Jacobs L (2008) Positive margins: the challenge continues for breast surgeons. Ann Surg Oncol 15:1271–1272PubMedCrossRef Jacobs L (2008) Positive margins: the challenge continues for breast surgeons. Ann Surg Oncol 15:1271–1272PubMedCrossRef
8.
Zurück zum Zitat Wazer DE, Schmidt-Ullrich RK, Ruthazer R, DiPetrillo T, Boyle T, Kanski J, Safaii H (1999) The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 45:885–891PubMedCrossRef Wazer DE, Schmidt-Ullrich RK, Ruthazer R, DiPetrillo T, Boyle T, Kanski J, Safaii H (1999) The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 45:885–891PubMedCrossRef
9.
Zurück zum Zitat Kreike B, Hart AA, van de Velde T, Borger J, Peterse H, Rutgers E, Bartelink H, van de Vijver MJ (2008) Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys 71:1014–1021PubMedCrossRef Kreike B, Hart AA, van de Velde T, Borger J, Peterse H, Rutgers E, Bartelink H, van de Vijver MJ (2008) Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys 71:1014–1021PubMedCrossRef
10.
Zurück zum Zitat Mannell A (2005) Breast-conserving therapy in breast cancer patients—a 12-year experience. S Afr J Surg 43:28–30 (discussion 30, 32)PubMed Mannell A (2005) Breast-conserving therapy in breast cancer patients—a 12-year experience. S Afr J Surg 43:28–30 (discussion 30, 32)PubMed
11.
Zurück zum Zitat Rubio IT, Marco V (2006) The importance of surgical margins in conservative surgery for breast cancer. Cir Esp 79:3–9PubMedCrossRef Rubio IT, Marco V (2006) The importance of surgical margins in conservative surgery for breast cancer. Cir Esp 79:3–9PubMedCrossRef
12.
Zurück zum Zitat Smitt MC, Horst K (2007) Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 14:1040–1044PubMedCrossRef Smitt MC, Horst K (2007) Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 14:1040–1044PubMedCrossRef
13.
Zurück zum Zitat Dillon MF, Hill AD, Quinn CM, McDermott EW, O’Higgins N (2006) A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 13:333–339PubMedCrossRef Dillon MF, Hill AD, Quinn CM, McDermott EW, O’Higgins N (2006) A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 13:333–339PubMedCrossRef
14.
Zurück zum Zitat Aziz D, Rawlinson E, Narod SA, Sun P, Lickley HL, McCready DR, Holloway CM (2006) The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 12:331–337PubMedCrossRef Aziz D, Rawlinson E, Narod SA, Sun P, Lickley HL, McCready DR, Holloway CM (2006) The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 12:331–337PubMedCrossRef
15.
Zurück zum Zitat Chagpar AB, Martin RC 2nd, Hagendoorn LJ, Chao C, McMasters KM (2004) Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg 188:399–402PubMedCrossRef Chagpar AB, Martin RC 2nd, Hagendoorn LJ, Chao C, McMasters KM (2004) Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg 188:399–402PubMedCrossRef
16.
Zurück zum Zitat Miller AR, Brandao G, Prihoda TJ, Hill C, Cruz AB Jr, Yeh IT (2004) Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol 86:134–140PubMedCrossRef Miller AR, Brandao G, Prihoda TJ, Hill C, Cruz AB Jr, Yeh IT (2004) Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol 86:134–140PubMedCrossRef
17.
Zurück zum Zitat Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA (2005) Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. J Surg Oncol 90:71–76PubMedCrossRef Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA (2005) Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. J Surg Oncol 90:71–76PubMedCrossRef
18.
Zurück zum Zitat Weng EY, Juillard GJ, Parker RG, Chang HR, Gornbein JA (2000) Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer 88:1643–1649PubMedCrossRef Weng EY, Juillard GJ, Parker RG, Chang HR, Gornbein JA (2000) Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer 88:1643–1649PubMedCrossRef
19.
Zurück zum Zitat Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ (2000) Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668–1675PubMed Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ (2000) Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668–1675PubMed
20.
Zurück zum Zitat Cao D, Lin C, Woo SH, Vang R, Tsangaris TN, Argani P (2005) Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. Am J Surg Pathol 29:1625–1632PubMedCrossRef Cao D, Lin C, Woo SH, Vang R, Tsangaris TN, Argani P (2005) Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. Am J Surg Pathol 29:1625–1632PubMedCrossRef
21.
Zurück zum Zitat Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, Salisbury E, Wong AY (2004) Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 100:1823–1832PubMedCrossRef Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, Salisbury E, Wong AY (2004) Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 100:1823–1832PubMedCrossRef
22.
Zurück zum Zitat Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455–1461PubMedCrossRef Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455–1461PubMedCrossRef
23.
Zurück zum Zitat Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, Tucker A, Dodge R, Leight G Jr, Iglehart JD et al (1993) Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218:22–28PubMedCrossRef Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, Tucker A, Dodge R, Leight G Jr, Iglehart JD et al (1993) Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218:22–28PubMedCrossRef
24.
Zurück zum Zitat Karni T, Pappo I, Sandbank J, Lavon O, Kent V, Spector R, Morgenstern S, Lelcuk S (2007) A device for real-time, intraoperative margin assessment in breast-conservation surgery. Am J Surg 194:467–473PubMedCrossRef Karni T, Pappo I, Sandbank J, Lavon O, Kent V, Spector R, Morgenstern S, Lelcuk S (2007) A device for real-time, intraoperative margin assessment in breast-conservation surgery. Am J Surg 194:467–473PubMedCrossRef
25.
Zurück zum Zitat Thill M, Roder K, Diedrich K, Dittmer C (2011) Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. Breast 20:579–580PubMedCrossRef Thill M, Roder K, Diedrich K, Dittmer C (2011) Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. Breast 20:579–580PubMedCrossRef
26.
Zurück zum Zitat Olson TP, Harter J, Munoz A, Mahvi DM, Breslin T (2007) Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol 14:2953–2960PubMedCrossRef Olson TP, Harter J, Munoz A, Mahvi DM, Breslin T (2007) Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol 14:2953–2960PubMedCrossRef
27.
Zurück zum Zitat Sobin LGM, Wittekind C (2009) TNM classification of malignant tumours. Wiley-Blackwell, Oxford Sobin LGM, Wittekind C (2009) TNM classification of malignant tumours. Wiley-Blackwell, Oxford
28.
Zurück zum Zitat Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB (2008) Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 15:2542–2549PubMedCrossRef Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB (2008) Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 15:2542–2549PubMedCrossRef
29.
Zurück zum Zitat Singletary SE (2002) Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184:383–393PubMedCrossRef Singletary SE (2002) Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184:383–393PubMedCrossRef
30.
Zurück zum Zitat Kerlikowske K (2010) Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010:139–141PubMedCrossRef Kerlikowske K (2010) Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010:139–141PubMedCrossRef
31.
Zurück zum Zitat Horner MJ, Ries L, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (2009) SEER Cancer Statistics Review, 1975–2006. National Cancer Institute, Bethesda, MD Horner MJ, Ries L, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (2009) SEER Cancer Statistics Review, 1975–2006. National Cancer Institute, Bethesda, MD
32.
Zurück zum Zitat Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913–918PubMedCrossRef Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913–918PubMedCrossRef
33.
Zurück zum Zitat Li CI, Daling JR, Malone KE (2005) Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 14:1008–1011PubMedCrossRef Li CI, Daling JR, Malone KE (2005) Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 14:1008–1011PubMedCrossRef
34.
Zurück zum Zitat Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA (2007) Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 99:1335–1339PubMedCrossRef Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA (2007) Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 99:1335–1339PubMedCrossRef
35.
Zurück zum Zitat Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA (2010) Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol 11:174–183PubMedCrossRef Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA (2010) Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol 11:174–183PubMedCrossRef
36.
Zurück zum Zitat Dawson SJ, Makretsov N, Blows FM, Driver KE, Provenzano E, Le Quesne J, Baglietto L, Severi G, Giles GG, McLean CA, Callagy G, Green AR, Ellis I, Gelmon K, Turashvili G, Leung S, Aparicio S, Huntsman D, Caldas C, Pharoah P (2010) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer 103:668–675PubMedCrossRef Dawson SJ, Makretsov N, Blows FM, Driver KE, Provenzano E, Le Quesne J, Baglietto L, Severi G, Giles GG, McLean CA, Callagy G, Green AR, Ellis I, Gelmon K, Turashvili G, Leung S, Aparicio S, Huntsman D, Caldas C, Pharoah P (2010) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer 103:668–675PubMedCrossRef
37.
Zurück zum Zitat Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25:5287–5312PubMedCrossRef Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25:5287–5312PubMedCrossRef
38.
Zurück zum Zitat Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, Hanby A, Brown J (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571PubMedCrossRef Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, Hanby A, Brown J (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571PubMedCrossRef
39.
Zurück zum Zitat Allweis TM, Kaufman Z, Lelcuk S, Pappo I, Karni T, Schneebaum S, Spector R, Schindel A, Hershko D, Zilberman M, Sayfan J, Berlin Y, Hadary A, Olsha O, Paran H, Gutman M, Carmon M (2008) A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery. Am J Surg 196:483–489PubMedCrossRef Allweis TM, Kaufman Z, Lelcuk S, Pappo I, Karni T, Schneebaum S, Spector R, Schindel A, Hershko D, Zilberman M, Sayfan J, Berlin Y, Hadary A, Olsha O, Paran H, Gutman M, Carmon M (2008) A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery. Am J Surg 196:483–489PubMedCrossRef
Metadaten
Titel
Predictors of resectability in breast-conserving therapy
verfasst von
Michelle G. Rath
Joerg Heil
Christoph Domschke
Zdravka Topic
Sven Schneider
Hans-Peter Sinn
Frederik Marme
Alexander Scharf
Andreas Schneeweiss
Christof Sohn
Joachim Rom
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2401-8

Weitere Artikel der Ausgabe 4/2012

Archives of Gynecology and Obstetrics 4/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.